|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.900 USD | +2.70% |
|
-11.63% | +38.69% |
| Market Cap | 656M 573M 529M 486M 921M 63.1B 937M 6.31B 2.48B 30.84B 2.46B 2.41B 106B | P/E 2026 * |
-2.71x | P/E 2027 * | -2.53x |
|---|---|---|---|---|---|
| Enterprise Value | 470M 411M 379M 349M 660M 45.23B 672M 4.53B 1.78B 22.11B 1.77B 1.73B 76.21B | EV / Sales 2026 * |
78,352x | EV / Sales 2027 * | 42.8x |
| Free-Float |
83.53% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Allogene Therapeutics, Inc.
| 1 day | +2.70% | ||
| 1 week | -11.63% | ||
| Current month | -8.65% | ||
| 3 months | -16.67% | ||
| 6 months | +11.76% | ||
| Current year | +38.69% |
| 1 week | 1.8 |  | 2.16 |
| 1 month | 1.8 | | 2.25 |
| Current year | 1.31 | | 4.46 |
| 1 year | 0.98 | | 4.46 |
| 3 years | 0.86 | | 5.78 |
| 5 years | 0.86 | | 27.86 |
| 10 years | 0.86 | | 55 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zachary Roberts
CEO | Chief Executive Officer | 48 | 01/07/2026 |
Geoffrey Parker
DFI | Director of Finance/CFO | 61 | 16/10/2023 |
Benjamin Beneski
CTO | Chief Tech/Sci/R&D Officer | 49 | 28/02/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Arie Belldegrun
CHM | Chairman | 76 | 01/11/2017 |
Joshua Kazam
BRD | Director/Board Member | 49 | 01/11/2017 |
Franz Humer
BRD | Director/Board Member | 79 | 01/04/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01/07 | Free | Chief Executive Officer | 610,720 | 0.1769% | ||
| 18/06 | Free | Director | 95,400 | 0.0276% | ||
| 18/06 | Free | Director | 95,400 | 0.0276% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.70% | -11.63% | +47.29% | -61.69% | 639M | |
| -1.39% | -7.58% | +54.00% | +124.73% | 54.49B | |
| +3.13% | +11.16% | +67.30% | +94.35% | 55.93B | |
| -0.27% | -2.69% | +7.77% | +433.06% | 23.87B | |
| +1.76% | -2.44% | -17.13% | -15.01% | 22.86B | |
| +3.51% | +7.50% | +47.81% | -3.33% | 20B | |
| +1.94% | -0.03% | +38.19% | -27.77% | 17.48B | |
| +10.00% | -2.06% | +210.10% | +370.99% | 15.39B | |
| +7.69% | +4.38% | +56.51% | +712.88% | 15.19B | |
| -0.39% | -2.68% | +21.87% | +186.49% | 14.02B | |
| Average | +2.87% | -1.09% | +53.37% | +181.47% | 23.99B | |
| Weighted average by Cap. | +2.10% | +0.44% | +52.34% | +169.39% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6K 5.25K 4.84K 4.45K 8.43K 577K 8.57K 57.77K 22.67K 282K 22.53K 22.04K 973K | 12.97M 11.34M 10.46M 9.62M 18.22M 1.25B 18.54M 125M 49.01M 610M 48.72M 47.65M 2.1B |
| Net income | -197M -172M -159M -146M -276M -18.91B -281M -1.89B -743M -9.24B -738M -722M -31.86B | -227M -199M -183M -168M -319M -21.86B -325M -2.19B -858M -10.68B -853M -834M -36.82B |
| Net Debt | -186M -162M -150M -138M -261M -17.87B -265M -1.79B -702M -8.73B -697M -682M -30.1B | -101M -88.13M -81.3M -74.73M -142M -9.7B -144M -971M -381M -4.74B -379M -370M -16.34B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/07/26 | USD 1.900 | +2.70% | 6,034,306 |
| 14/07/26 | USD 1.850 | -4.15% | 5,422,350 |
| 13/07/26 | USD 1.930 | -3.50% | 8,941,923 |
| 10/07/26 | USD 2.000 | -4.76% | 7,779,892 |
| 09/07/26 | USD 2.100 | -0.94% | 6,544,217 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALLO Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
